Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Meier

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Introduction: Osteoporosis]Christian Meier
Annales D'Endocrinologie|April 28, 2015
Benefits and place of calcimimetics in the management of primary hyperparathyroidismChristian Meier
Praxis|October 8, 2009
[Osteoporosis: diagnostic assessment]Christian Meier
Therapeutische Umschau. Revue Therapeutique|March 28, 2014
[In Process Citation]Marius Kraenzlin, Christian Meier
Swiss Medical Weekly|May 16, 2023
Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)Serge Ferrari, Christian Meier
Swiss Medical Weekly|September 2, 2011
Calcium supplementation, osteoporosis and cardiovascular diseaseChristian Meier, Marius E Kränzlin
Expert Opinion on Biological Therapy|January 27, 2006
Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancerMarius E Kraenzlin, Christian Meier
Nature Reviews. Endocrinology|July 14, 2011
Parathyroid hormone analogues in the treatment of osteoporosisMarius E Kraenzlin, Christian Meier
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Antiepileptics and bone healthChristian Meier, Marius E Kraenzlin
Nature Clinical Practice. Endocrinology & Metabolism|August 19, 2007
Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?Marius E Kraenzlin, Christian Meier
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Introduction: Osteoporosis]Christian Meier
Annales D'Endocrinologie|April 28, 2015
Benefits and place of calcimimetics in the management of primary hyperparathyroidismChristian Meier
Praxis|October 8, 2009
[Osteoporosis: diagnostic assessment]Christian Meier
Therapeutische Umschau. Revue Therapeutique|March 28, 2014
[In Process Citation]Marius Kraenzlin, Christian Meier
Swiss Medical Weekly|May 16, 2023
Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)Serge Ferrari, Christian Meier
Swiss Medical Weekly|September 2, 2011
Calcium supplementation, osteoporosis and cardiovascular diseaseChristian Meier, Marius E Kränzlin
Expert Opinion on Biological Therapy|January 27, 2006
Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancerMarius E Kraenzlin, Christian Meier
Nature Reviews. Endocrinology|July 14, 2011
Parathyroid hormone analogues in the treatment of osteoporosisMarius E Kraenzlin, Christian Meier
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Antiepileptics and bone healthChristian Meier, Marius E Kraenzlin
Nature Clinical Practice. Endocrinology & Metabolism|August 19, 2007
Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?Marius E Kraenzlin, Christian Meier
Pageof 16